Literature DB >> 20952880

Colchicine in the treatment of subcorneal pustular dermatosis.

K Pavithran1.   

Abstract

A male patient with subcorneal pustular dermatosis was initially treated with dapsone with excellent response. Since he developed hypersensitivity to dapsone, corticosteroid was given instead of dapsone. But steroid also was withdrawn since he developed hypertension and diabetes. There was relapse of skin lesions which were treated with oral colchicine, which has profound inhibitory effects on neutrophils. There was excellent therapeutic response to colchicine and the drug well-tolerated.

Entities:  

Year:  1995        PMID: 20952880

Source DB:  PubMed          Journal:  Indian J Dermatol Venereol Leprol        ISSN: 0378-6323            Impact factor:   2.545


  5 in total

1.  Colchicine in the treatment of refractory aphthous ulcerations: Review of the literature and two case reports.

Authors:  Mihaela Paula Toader; Irina Mihaela Esanu; Tatiana Taranu; Madalina Mocanu; Stefan Toader
Journal:  Exp Ther Med       Date:  2021-01-25       Impact factor: 2.447

2.  First presentation of Sneddon-Wilkinson disease with unexpected immunoglobulin A gammopathy: A case report and review of the literature.

Authors:  Julia Mayba; C Nicole Hawkins
Journal:  SAGE Open Med Case Rep       Date:  2019-01-30

3.  Subcorneal Pustular Dermatosis in Paediatrics: A Case Report and Review of the Literature.

Authors:  Mais A Alhafi; Mohamed I Janahi; Zainab N Almossalli
Journal:  Cureus       Date:  2021-12-06

Review 4.  Colchicine in Managing Skin Conditions: A Systematic Review.

Authors:  Stefano Dastoli; Steven Paul Nisticò; Pietro Morrone; Cataldo Patruno; Antonio Leo; Rita Citraro; Luca Gallelli; Emilio Russo; Giovambattista De Sarro; Luigi Bennardo
Journal:  Pharmaceutics       Date:  2022-01-27       Impact factor: 6.321

5.  Subcorneal pustular dermatosis masquerading as dermatophytosis.

Authors:  Jayakar Thomas; K Parimalam
Journal:  Indian Dermatol Online J       Date:  2012-09
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.